Omicron News and Research

RSS

How does Omicron BA.1 infection impact the risk of reinfection with BA.5?

Researchers found prior exposure to SARS-CoV-2 Omicron sub-variants BA.1/BA.2 reduced the risk of breakthrough infection by its sub-variant BA.5.

2 Aug 2022

What are the hidden sources of SARS-CoV-2 evolution?

A recent article published in Transplant Infectious Disease examined case reports on SARS-CoV-2 evolution in immunosuppressed cohorts.

2 Aug 2022

The time has come for DIY mandates on covid

Here we are in the grip of yet another covid-19 surge, yet most people I see out and about are behaving as if the pandemic is over. And I live in Los Angeles County, whose public health department is arguably one of the most vigilant and proactive in the U.S.

2 Aug 2022

What is the efficacy of COVID-19 BNT162b2 and mRNA-1273 booster vaccinations?

In a new study, scientists compared the effectiveness of the SARS-CoV-2 BNT162b2 and mRNA-1273 vaccines booster doses in England.

2 Aug 2022

The efficacy of honokiol in inhibiting SARS-CoV-2 replication in cell culture

Researchers evaluated the efficacy of honokiol in inhibiting SARS-CoV-2 replication in cell cultures.

2 Aug 2022

Reduced severity of COVID-19 in pregnant women during the Omicron wave

A new study assesses the clinical outcomes of COVID-19 in pregnant women to determine whether Omicron and vaccination status impacted disease severity.

1 Aug 2022

Nasal epithelium of children inhibits infection and replication of ancestral SARS-CoV-2

SARS-CoV-2 causes a broad range of clinical symptoms, including potentially fatal acute respiratory distress syndrome (ARDS).

1 Aug 2022

Study: SARS-CoV-2 variants of concern and biological sex of patients affect molnupiravir efficacy

SARS-CoV-2 variants of concern and the biological sex of patients affect the efficacy of molnupiravir, the first orally available drug approved for outpatient use against COVID-19, according to a new study led by researchers in the Center for Translational Antiviral Research in the Institute for Biomedical Sciences at Georgia State University.

1 Aug 2022

Researchers find decline in life expectancy among Native Americans due to COVID-19

Native Americans experienced disproportionately high rates of deaths from COVID-19 due to poverty, crowded housing, high rates of chronic disease, employment in frontline jobs, and limited access to quality health care.

1 Aug 2022

Study finds a column containing a Galanthus nivalis agglutinin affinity resin can bind all the major COVID-19 variants

Researchers assessed the binding of Galanthus nivalis agglutinin to SARS-CoV-2 variants.

1 Aug 2022

Decoy ACE2 receptors broadly neutralize SARS-CoV-2 variants

Researchers review current developments in preclinical studies associated with recombinant ACE2 decoy receptors against coronaviruses.

31 Jul 2022

Hypertension heightens the risk of hospitalization related to SARS-CoV-2 Omicron infection

Hypertension more than doubles the risk of hospitalization related to Omicron infection, even in people who are fully vaccinated and boosted, according to a new study led by investigators in the Smidt Heart Institute at Cedars-Sinai.

29 Jul 2022

Survey: Nearly 1 in 5 Americans are concerned about contracting monkeypox

As Covid-19 cases surge across the United States dominated by a highly transmissible subvariant and worry about Covid persists, some in the public have begun to voice concern about the new health threat of monkeypox, according to a new Annenberg Public Policy Center national survey.

29 Jul 2022

SARS-CoV-2 spike subunit 2–targeted vaccine could more effectively combat all human coronaviruses

In a new study, researchers evidenced that the S2 subunit of SARS-CoV-2 spike (S) could be an integral component of a pan-coronavirus vaccine.

29 Jul 2022

Tannins as therapeutic agents against SARS-CoV-2

Researchers reviewed tannins as therapeutic agents against SARS-CoV-2.

29 Jul 2022

To what extent did the COVID-19 booster strategy prevent infections and hospitalizations in US adults?

Researchers estimated the impact of different COVID-19 mRNA booster vaccinations in the United States during fall 2022.

29 Jul 2022

TMPRSS2 protein, a novel target for SARS-CoV-2 drugs

A new study reports the activity of a compound which inhibited TMPRSS2, ultimately preventing severe COVID-19.

28 Jul 2022

Predicting viral antibody escape using pre-pandemic data

A new study reports early prediction of SARS-CoV-2 immune evasion using EVEscape.

28 Jul 2022

Less than half of Genevans have antibodies neutralizing Omicron sub-variants, study shows

A study by the Geneva University Hospitals (HUG), the Faculty of Medicine of the University of Geneva and the EPFL shows that almost all Genevans (93.8%) have antibodies against SARS-CoV 2, almost three quarters of whom acquired them through an infection.

28 Jul 2022

Accurate rapid-testing device displays antibody levels in an easily readable way

Vaccines have become the most important weapon in the fight against the COVID-19 pandemic, but antibody levels after vaccination decay quickly over time.

28 Jul 2022

Omicron News and Research

How does Omicron BA.1 infection impact the risk of reinfection with BA.5?

What are the hidden sources of SARS-CoV-2 evolution?

The time has come for DIY mandates on covid

What is the efficacy of COVID-19 BNT162b2 and mRNA-1273 booster vaccinations?

The efficacy of honokiol in inhibiting SARS-CoV-2 replication in cell culture

Reduced severity of COVID-19 in pregnant women during the Omicron wave

Nasal epithelium of children inhibits infection and replication of ancestral SARS-CoV-2

Study: SARS-CoV-2 variants of concern and biological sex of patients affect molnupiravir efficacy

Researchers find decline in life expectancy among Native Americans due to COVID-19

Study finds a column containing a Galanthus nivalis agglutinin affinity resin can bind all the major COVID-19 variants

Decoy ACE2 receptors broadly neutralize SARS-CoV-2 variants

Hypertension heightens the risk of hospitalization related to SARS-CoV-2 Omicron infection

Survey: Nearly 1 in 5 Americans are concerned about contracting monkeypox

SARS-CoV-2 spike subunit 2–targeted vaccine could more effectively combat all human coronaviruses

Tannins as therapeutic agents against SARS-CoV-2

To what extent did the COVID-19 booster strategy prevent infections and hospitalizations in US adults?

TMPRSS2 protein, a novel target for SARS-CoV-2 drugs

Predicting viral antibody escape using pre-pandemic data

Less than half of Genevans have antibodies neutralizing Omicron sub-variants, study shows

Accurate rapid-testing device displays antibody levels in an easily readable way

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News